Author:
Liang Raymond,Chan T. K.,Chiu Edmond,Todd David
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference12 articles.
1. Allen SL, Coleman M (1985) Terminal-phase chronic myelogenous leukemia: approaches to treatment. Cancer Invest 3: 491?503
2. Anger B, Heimpel H (1989) Dauhorubicin, cytosine arabinoside and VP-16 (DAV) for myeloid blast crisis of CML. Blut 58: 299?301
3. Bassab R, Battista R, Comotti B, Minetti B, Chisesi T, Dini E, Barbui T (1987) Treatment of the lymphoid blast crisis of chronic myeloid leukaemia. Eur J Cancer Clin Oncol 23: 513?515
4. Dutcher JP, Wiernik PH, Arlin Z, Paietta E, Rowe J, Kellermeyer R, Anderson J (1989) Mitoxantrone and 5-azacytidine for patients with accelerated or blastic crisis chronic myeloid leukaemia. Proc Annu Meet Am Soc Clin Oncol 8: A797
5. Kantarjian HM, Keating MJ, Talpaz M, Walters RS, Smith TL, Cork A, McCredie KB, Freireich EJ (1987) Chronic myelogenous leukemia in blastic crisis, analysis of 242 patients. Am J Med 83: 445?454
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献